PhAST Diagnostics
PrivateLast Round
Series B
May 8, 2025
Total Funding Raised
$18.57M
Company Overview
PhAST Diagnostics operates in Healthcare & Life Sciences and is based in Boston, Massachusetts. Its latest recorded funding round was a Series B round in May 2025.
PhAST Diagnostics is a healthcare technology company that develops an AI-powered, cloud-based platform for rapid infectious disease diagnostics to combat antibiotic resistance.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Medical Devices, Biotechnology, Computer Vision, Drug Discovery
Business Model
B2B
Customer Profile
Hardware + Subscription, Usage-Based SaaS, Hardware Sales, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PhAST Diagnostics Comparables
Compare PhAST Diagnostics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Resistell AG | 88% | |
| Pattern Bioscience | 87% | |
| SeLux Diagnostics | 86% |
For institutional investors. Book with your work email.
PhAST Diagnostics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 8, 2025 | ||||
| Series A | Jan 18, 2022 | ||||
| Grant | Sep 3, 2019 | ||||
| Grant | Aug 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
PhAST Diagnostics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SV Investment | Series A |
| National Institute of Allergy and Infectious Diseases | Grant |
| Massachusetts Life Sciences Center | Grant |
| Longitude Prize on Dementia | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 8, 2025
$3.47M round raised
- Apr 14, 2024
Grew 17% QoQ, from 24 to 28 employees.
For institutional investors. Book with your work email.
PhAST Diagnostics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PhAST Diagnostics's valuation, stock price, and market status.
Is PhAST Diagnostics a public or private company?
PhAST Diagnostics is a private company.
What is the current stock price of PhAST Diagnostics?
PhAST Diagnostics is a private company, so its shares have no public market price. Caplight tracks PhAST Diagnostics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PhAST Diagnostics worth (valuation)?
Valuation information for PhAST Diagnostics is not publicly available.
Can I buy PhAST Diagnostics stock?
PhAST Diagnostics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PhAST Diagnostics's last funding round?
PhAST Diagnostics's most recent funding round was Series B on May 8, 2025.
Who are the main investors in PhAST Diagnostics?
Key investors in PhAST Diagnostics include SV Investment.
Will PhAST Diagnostics IPO soon?
No public IPO plans have been announced for PhAST Diagnostics.
How can I track PhAST Diagnostics secondary market activity?
Caplight tracks bids, offers, and trades in PhAST Diagnostics's shares on secondary markets.